• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Global Education Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
538406
INE291W01037
24.2429594
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLOBAL
21.23
524.18
EPS(TTM)
Face Value()
Div & Yield %
4.85
2
0.49
 

Oxygenta Pharmaceutical reports standalone net loss of Rs 4.84 crore in the December 2025 quarter
Feb 05,2026
Net Loss of Oxygenta Pharmaceutical reported to Rs 4.84 crore in the quarter ended December 2025 as against net loss of Rs 3.93 crore during the previous quarter ended December 2024. Sales rose 2.17% to Rs 33.93 crore in the quarter ended December 2025 as against Rs 33.21 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales33.9333.21 2
OPM %-12.00-13.10 -
PBDT-5.46-4.25 -28
PBT-6.32-4.96 -27
NP-4.84-3.93 -23